Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × blinatumomab × 1 year × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 36 Burkitt Lymphoma 23 Neoplasm, Residual 8 Leukemia 7 Leukemia, Biphenotypic, Acute 6 Recurrence 5 Lymphoma, Non-Hodgkin 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Lymphoma 3 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Myelodysplastic Syndromes 2 Leukemia, Myelomonocytic, Juvenile 2 Leukemia, Myeloid, Acute 2 Blast Crisis 2 Sarcoma, Myeloid 1 Myasthenia Gravis 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myeloid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Large Granular Lymphocytic 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Graft vs Host Disease 1 Down Syndrome 1 Bites and Stings 1

Interventions

fludarabine 4 Cisplatin 4 Pemetrexed 3 Cyclophosphamide 3 pralsetinib 2 pembrolizumab 2 fludarabine phosphate 2 durvalumab 2 cobimetinib 2 atezolizumab 2 Whole-Body Irradiation 2 Vemurafenib 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Paclitaxel 2 Nivolumab 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Busulfan 2 130-nm albumin-bound paclitaxel 2 trametinib 1 spartalizumab 1 ruxolitinib 1 repotrectinib 1 ponatinib 1 pertuzumab 1 gilteritinib 1 enzalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡